REQUEST A DEMO
Total
USD $0.00
Search more companies

Irvin 2 OOO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Irvin 2 OOO Profile Updated: September 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

In June 2009 the company IRWIN 2 has become part of a pharmaceutical holding FarmEko. Holding companies operating in the pharmaceutical market since 2001, specializing in the following areas: supply of medicines as part of the social importance of public projects for the prevention and treatment of oncological diseases, tuberculosis, hepatitis A and B, HIV infection, additional preferential provision of medicines, including high-cost nosology, the delivery of medical products and medical equipment in health facilities, research activities in the field of targeted drug delivery systems based on nanotechnology and the development of innovative medicines based on the synthetic polynucleotides (aptamer).

Headquarters
Kotelinicheskaya, 13, 11, Komnata 1
Lyubertsy; Moscow Oblast; Postal Code: 140000

Contact Details: Purchase the Irvin 2 OOO report to view the information.

Website: http://irwin2.ru

Basic Information
Outstanding Shares:
Purchase the Irvin 2 OOO report to view the information.
Registered Capital:
Purchase the Irvin 2 OOO report to view the information.
Incorporation Date:
January 27, 2003
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Irvin 3 OOO
95%
Fabrika Biopolimerov OOO
51%
Company Performance
Financial values in the chart are available after Irvin 2 OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
6.66%
Total operating revenue
6.66%
Operating profit (EBIT)
46.35%
Net Profit (Loss) for the Period
74.16%
Total assets
-8.64%
Total equity
22.16%
Operating Profit Margin (ROS)
3.3%
Net Profit Margin
3.5%
Return on Equity (ROE)
18.83%
Debt to Equity Ratio
66.65%
Quick Ratio
0.74%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?